Course Overview
This event will take place twice on March 27th, 2023
First schedule: 1pm EDT / 7pm CET
Second schedule: 7pm EDT / 1am CET (+1)
This expert webinar is designed to raise awareness for HCM and provide knowledge around HCM diagnosis. It assists primary healthcare professionals to:
- recognize symptoms that may suggest a diagnosis of HCM and physical examination findings that merit further investigation and / or referral to secondary care
- better describe pharmaceutical treatments for heart failure symptoms and identify potential drug–drug interactions in HCM patients
This webinar is 60 minutes duration.
Target audience
Family/general/internal medicine physicians, nurse practitioners, registered nurses, clinical nurse specialists, physician assistants, pediatricians, pediatric nurses.
Funding disclosure
This activity is supported by educational grant funding from Bristol Myers Squibb and Cytokinetics. Learners may participate in this educational activity free of charge.
- Introduction to hypertrophic cardiomyopathy (HCM)
- HCM presentation, patient symptoms, diagnosis, and referral
- Therapeutic goals and a brief introduction to pharmacotherapies
- Q&A and closing remarks
By the end of this activity, attendees will be able to:
- recognize symptoms that may suggest a diagnosis of HCM
- outline ECG and physical examination findings that are suggestive of HCM and merit referral to secondary care, and apply to an example patient
- summarize diagnostic differences between HCM and other diseases that can cause left ventricular hypertrophy (LVH) and apply this information to appropriately diagnose patients
- identify key drug–drug interactions which should be considered in patients with HCM and comorbidities requiring pharmacological treatment, and apply to an example patient
This continuing education (CE) activity is provided through collaboration between PCM Scientific and AffinityCE. This activity provides CE credit for physicians, physician assistants, nurses and nurse practitioners. A statement of participation is available to other attendees.
Physicians
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AffinityCE and PCM Scientific. AffinityCE is accredited by the ACCME to provide continuing medical education for physicians.
AffinityCE designates this enduring activity for a maximum of up to 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physician Assistants
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AffinityCE and PCM Scientific. AffinityCE is accredited by the ACCME to provide continuing medical education for physicians.
AffinityCE designates this enduring activity for a maximum of up to 1.0 AMA PRA Category 1 Credits™. Physician assistants should claim only the credit commensurate with the extent of their participation in the activity.
Nurse Practitioners
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AffinityCE and PCM Scientific. AffinityCE is accredited by the ACCME to provide continuing medical education for physicians.
AffinityCE designates this enduring activity for a maximum of up to 1.0 AMA PRA Category 1 Credits™. Nurse practitioners should claim only the credit commensurate with the extent of their participation in the activity.
Nurses
Continuing Nursing Education is provided for this program through the joint providership between PCM Scientific and AffinityCE. AffinityCE is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation (ANCC). This activity provides a maximum of up to 1.0 contact hours of continuing nursing education credit.
CME Inquiries
For all CME policy-related inquiries, please contact us at ce@affinityced.com.
Dr Anjali Owens, MD, Associate Professor of Medicine, University of Pennsylvania, has received financial compensation for consulting for Bristol Myers Squibb, Cytokinetics, Pfizer, Edgewise Therapeutics, Renovacor/Rocket, Stealth Biotherapeutics, Lexicon Pharmaceuticals, Tenaya Therapeutics, and received research grants from Bristol Myers Squibb and Cytokinetics.
Dr Lubna Choudhury, MD, Professor of Medicine, Northwestern University, has received research grants from Bristol Myers Squibb and Cytokinetics.
AffinityCE staff, PCM Scientific staff, as well as planners and reviewers have no relevant financial interests to disclose.
Mitigation of relevant financial relationships
AffinityCE adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant financial relationships have been mitigated prior to the commencement of the activity.